According to a study presented at the American Society of Clinical Oncology’s 2024 annual meeting, artificial intelligence may be able to reach underserved populations by re-engaging individuals who previously missed or avoided an appointment.
After researchers used an AI tool to reengage 2,400 patients who missed colonoscopies, 58% of patients who engaged with the AI accepted a live transfer to a staff member to reschedule their appointments, and 25% of patients completed their colonoscopy screening.
Additionally, giving patients more choice in their colorectal cancer screening options could increase the number of patients who get screened, according to a May study from the Perelman School of Medicine in Philadelphia.
When patients were given the choice between a take-home test kit or undergoing a colonoscopy, more patients voluntarily undergo screenings.
These two studies may show health systems effective ways to engage patients for routine screenings as colorectal cancer rates continue to rise nationwide.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.